CERo Therapeutics Inc. (CERO)
NASDAQ: CERO
· Real-Time Price · USD
8.10
0.10 (1.25%)
At close: Aug 18, 2025, 10:37 AM
CERo Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
PE Ratio | -1.23 | -17.15 | -2.74 | -4.54 | -44.28 | -56.85 | -737.05 | -117.98 | -99.2 | -661.53 | 6.86K | -5.16K | -1.52K | -1.81K | n/a | -580.76K |
PEG Ratio | 0.00 | 0.17 | 0.06 | 1.36 | 0.48 | -0.04 | 20.73 | 8.30 | -0.17 | 0.57 | -39 | 73.17 | -75.46 | n/a | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -75.96 | -76.51 | -12.52 | -17.92 | -275.41 | -11.16 | -179.7 | 1.8K | 486.87 | 281.56 | 13.61 | 13.52 | 13.50 | 13.33 | n/a | 96.79K |
P/FCF Ratio | -5.63 | 34.97 | -35.16 | -12.57 | -80.19 | -344.54 | -3.84K | -476.2 | -673.36 | -1.86K | -13.3K | -9.73K | -7.47K | -3.27K | n/a | n/a |
P/OCF Ratio | -5.63 | 34.97 | -35.16 | -12.57 | -80.19 | -344.54 | -3.84K | -476.2 | -673.36 | -1.86K | -13.3K | -9.73K | -7.47K | -3.27K | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -4.15 | -0.83 | -0.49 | -0.87 | -1.73 | -0.27 | -0.25 | 2.14 | 0.33 | 0.26 | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 0.73 | 0.50 | 0.39 | 0.48 | 0.47 | 1.65 | 1.76 | 3.20 | 0.12 | 1.38 | 0.90 | 3.61 | 6.28 | 13.88 | 0.09 | 24.00 |
Current Ratio | 0.73 | 0.50 | 0.39 | 0.48 | 0.47 | 1.65 | 1.76 | 3.20 | 0.12 | 1.38 | 0.90 | 3.61 | 6.28 | 13.88 | 0.09 | 24.00 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | 78.76 | n/a | -303.25 | -472.75 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | 15.50 | 1.12 | 1.14 | 0.99 | 1.55 | 0.05 | 0.06 | -3.81 | -1.23 | -0.11 | n/a | n/a | n/a | n/a | n/a | -0.04 |
Return on Assets | -0.64 | -0.34 | -0.65 | -0.33 | -0.2 | -0.03 | -0.04 | -0.15 | -0.17 | -0.01 | n/a | n/a | n/a | n/a | n/a | -0.04 |
Return on Invested Capital | -4.77 | -3.76 | 2.32 | 15.41 | 3.25 | -0.05 | -0.06 | -0.11 | -0.02 | 0.10 | n/a | n/a | n/a | n/a | n/a | -0.04 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |